<DOC>
	<DOCNO>NCT02400632</DOCNO>
	<brief_summary>The purpose study demonstrate efficacy MagicTouch DCB reduce late lumen loss / suppress neointimal tissue formation assess Quantitative Coronary Angiography / Intravascular Ultrasound examination treatment coronary artery lesion range 3.0 mm 3.5 mm diameter lesion length ≤ 15 mm .</brief_summary>
	<brief_title>MagicTouch Sirolimus Drug Coated Balloon Catheter Treatment Coronary Lesions</brief_title>
	<detailed_description>Prospective , multicenter , randomize study design enroll 60 subject In-stent Restenosis , To demonstrate efficacy MagicTouch Drug-Coated Balloon reduce late lumen loss / suppress neointimal tissue formation assess Quantitative Coronary Angiography / Intravascular Ultrasound examination treatment coronary artery lesion range 3.0 mm 3.5 mm diameter lesion length ≤ 15 mm .</detailed_description>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Sirolimus</mesh_term>
	<criteria>1 . The patient must ≥18 ≤ 80 year age 2 . Symptomatic ischemic heart disease ; 3 . Acceptable candidate Coronary Artery Bypass Graft ( CABG ) Angioplasty ; 4 . Target lesion locate native coronary artery 5 . Target lesion ( maximum length 15 mm visual estimate ) cover single balloon ; 6 . Reference vessel diameter must ≥3.0 ≤ 3.5 mm visual estimate ; 7 . Target lesion ≥50 % &lt; 100 % stenosed visual estimate 8 . Restenosis initially stented main vessel . 1 . Pregnant nursing patient plan pregnancy period 1 year follow index procedure ; 2 . Patient known diagnosis acute myocardial infarction ( AMI ) within 72 hour precede index procedure ; 3 . Lesions bypass grafts bifurcation 4 . Any nontarget vessel lesion intend treated index procedure , unprotected leave main , ostial lesion , chronic total occlusion ( CTO ) , heavily calcify , bifurcation , vein graft , angiographic evidence thrombus , anything require atherectomy , thrombectomy , pretreatment anything balloon angioplasty ; 5 . Patient present cardiogenic shock ; 6 . Patient extensive peripheral vascular disease precludes safe 6 French sheath insertion 7 . Unprotected leave main coronary artery disease ≥50 % stenosis ; 8 . Totally occluded target vessel ( TIMI flow 0 ) ; 9 . Calcified target lesion ( ) successfully predilated ; 10 . A significant ( &gt; 50 % ) stenosis proximal distal target lesion cover single balloon 11 . Diffuse distal disease target lesion impair runoff ; 12 . Left ventricular ejection fraction ( LVEF ) ≤30 % ( LVEF must obtain within 1 month prior index procedure ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>drug-eluting balloon</keyword>
	<keyword>in-stent restenosis</keyword>
</DOC>